# FDA 483 - AstraZeneca Pharmaceuticals LP - March 19, 2021

Source: https://www.globalkeysolutions.net/records/483/astrazeneca-pharmaceuticals-lp/630d6419-c15c-4d90-ad6a-ae10c07c6f0f

> FDA 483 for AstraZeneca Pharmaceuticals LP on March 19, 2021. Product: drugs. Access full analysis and detailed observations.

---

## Details

- Record Type: 483
- Company Name: AstraZeneca Pharmaceuticals LP
- Inspection Date: 2021-03-19
- Product Type: drugs
- Office Name: Division of Clinical Evidence and Analysis 1 (Clinical Policy and Quality)

## Related Documents

- [WARNING_LETTER - 2023-08-15](https://www.globalkeysolutions.net/records/warning_letter/astrazeneca-pharmaceuticals-lp/ffb41aa4-e9b4-4e4e-b72f-9cf78acb857c)
- [483 - Unknown Date](https://www.globalkeysolutions.net/records/483/astrazeneca-pharmaceuticals-lp/18be36a6-b748-456a-9e2b-93a50fc65442)
- [483 - 2023-01-19](https://www.globalkeysolutions.net/records/483/astrazeneca-pharmaceuticals-lp/478db057-80d8-4a2c-947c-22026c39adb6)
- [EIR - Unknown Date](https://www.globalkeysolutions.net/records/eir/astrazeneca-pharmaceuticals-lp/3d033ebe-b0ca-4656-8ab5-10333ded858b)
- [483 - 2024-06-07](https://www.globalkeysolutions.net/records/483/astrazeneca-pharmaceuticals-lp/f295582f-0d0d-456b-8a87-9c3c9acec931)

## Related Officers

- [Zhao Wang, Chemist, Ph.D.](https://www.globalkeysolutions.net/people/zhao-wang-chemist-phd/5c97ae2a-0968-4e26-8785-4854d8503d05)
- [FDA Biologics Investigator](https://www.globalkeysolutions.net/people/viviana-matta/6fecf0ca-0edc-4538-a57e-72642f41b5c7)
- [Haohong Yan, Lead Chemist, Ph.D.](https://www.globalkeysolutions.net/people/haohong-yan-lead-chemist-phd/d0059cc8-8f07-4a82-8533-f920dca79017)

Company: https://www.globalkeysolutions.net/companies/astrazeneca-pharmaceuticals-lp/6f9abb75-9352-43df-b761-026089396fa3

Office: https://www.globalkeysolutions.net/offices/division-of-clinical-evidence-and-analysis-1-clinical-policy-and-quality/5f95da17-30bb-423f-b892-5ea041823fbd